Drug side effects
Study seeks to clarify true incidence of statin intolerance
Around 40% of patients experienced intolerable muscle symptoms during atorvastatin treatment, but not with placebo.
Source: Libby Welch / Alamy Stock Photo
Between 5% and 20% of patients receiving statins report that they experience muscle-related intolerance, such as pain or weakness, which often results in discontinuation of treatment. But as these symptoms are self-reported, there has been doubt over the true incidence.
In a paper published in JAMA (online, 3 April 2016), researchers explored this by performing a crossover study in which 511 patients with a history of intolerance were randomly assigned to receive atorvastatin or placebo for ten weeks before switching to the other treatment.
Overall, 42.6% of patients experienced intolerable muscle symptoms during atorvastatin treatment, but not with placebo. However, 26.5% of patients only reported symptoms during the placebo phase, suggesting their symptoms were not statin related.
The researchers say their study may underestimate the incidence of atorvastatin intolerance as the dose was 20mg and symptoms are dose related.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20200987
Recommended from Pharmaceutical Press
Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.£38.00
FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.£25.00
Introduction to Pharmaceutical Calculations is an essential study aid for pharmacy students. The book contains worked examples and sample questions and answers.£33.00
Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.£43.00
Pharmacy Registration Assessment Questions features over 400 closed book and calculation questions. With the registration exam having gone through a complete transformation in 2016, this volume has been developed around the new General Pharmaceutical Council (GPhC) guidelines.£33.00